Wells Fargo’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-167,484	Closed	-$1.65M	–	7281
2021 Q1	$1.65M	Buy	+167,484	New	+$1.65M	﹤0.01%	3633